European regulators gave Canada-based ARTMS Products the CE mark for its Quantm irradiation system, which produces technetium-99m and gallium-68. The system, developed along with the TRIUMF particle accelerator center in Canada and researchers at three Canadian health research institutes, may reduce radioisotope costs and supply issues, said ARTMS CEO Kaley Wilson.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.